UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Nature communications, 2021-05, Vol.12 (1), p.2540-2540, Article 2540

2021

Volltextzugriff (PDF)

Pyrotinib in HER2 -Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

Journal of clinical oncology, 2020-08, Vol.38 (24), p.2753-2761

2020

Volltextzugriff (PDF)

Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers

BMC cancer, 2018-03, Vol.18 (1), p.267-267, Article 267

2018

Volltextzugriff (PDF)

A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer

Oncoimmunology, 2022-12, Vol.11 (1), p.2028962-2028962

2022

Volltextzugriff (PDF)

Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7

Cell reports (Cambridge), 2017-01, Vol.18 (5), p.1229-1240

2017

Volltextzugriff (PDF)

Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study

BMC infectious diseases, 2024-01, Vol.24 (1), p.28-28, Article 28

2024

Volltextzugriff (PDF)

Numerical simulation and validation of local wind environment of twin-box girder with wind barriers

Advances in bridge engineering, 2023-07, Vol.4 (1), p.13-21, Article 13

2023

Volltextzugriff (PDF)

Identification and validation of a pyroptosis-related signature in identifying active tuberculosis via a deep learning algorithm

Frontiers in cellular and infection microbiology, 2023-11, Vol.13, p.1273140-1273140

2023

Volltextzugriff (PDF)

Lung cancer in China: current and prospect

Current opinion in oncology, 2021-01, Vol.33 (1), p.40-46

2021

Volltextzugriff (PDF)

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

Frontiers in oncology, 2021-03, Vol.11, p.639947-639947

2021

Volltextzugriff (PDF)

Beyond Osimertinib: The Development of Third-Generation EGFR Tyrosine Kinase Inhibitors For Advanced EGFR+ NSCLC

Journal of thoracic oncology, 2021-05, Vol.16 (5), p.740-763

2021

Volltextzugriff (PDF)

Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway

Experimental hematology & oncology, 2023-07, Vol.12 (1), p.61-61, Article 61

2023

Volltextzugriff (PDF)

TLR9 is a Cancer Stem Cell Maintenance Marker in Non-small Cell Lung Cancer

Chest, 2016-04, Vol.149 (4), p.A323-A323

2016

Volltextzugriff (PDF)

Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer

Clinical and translational medicine, 2024-04, Vol.14 (4), p.e1649-n/a

2024

Volltextzugriff (PDF)

Advances in modeling boundary layer turbulence and its effects on motion independent aerodynamic force of bridge decks

Advances in bridge engineering, 2022-12, Vol.3 (1), p.28-21, Article 28

2022

Volltextzugriff (PDF)

A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease

Cancer medicine (Malden, MA), 2023-05, Vol.12 (10), p.11375-11384

2023

Volltextzugriff (PDF)

Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006234

2023

Volltextzugriff (PDF)

Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction

Journal of hematology and oncology, 2018-09, Vol.11 (1), p.117-117, Article 117

2018

Volltextzugriff (PDF)

Synchronous ground‐glass nodules showed limited response to anti‐PD‐1/PD‐L1 therapy in patients with advanced lung adenocarcinoma

Clinical and translational medicine, 2020-07, Vol.10 (3), p.n/a

2020

Volltextzugriff (PDF)

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease

Thoracic cancer, 2024-04, Vol.15 (10), p.778-787

2024

Volltextzugriff (PDF)

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation

Chinese medical journal, 2023-04, Vol.136 (7), p.848-850

2023

Volltextzugriff (PDF)

Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study

Therapeutic advances in medical oncology, 2022-01, Vol.14, p.175883592211367-17588359221136759

2022

Volltextzugriff (PDF)

Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trials

Experimental hematology & oncology, 2023-06, Vol.12 (1), p.53-53, Article 53

2023

Volltextzugriff (PDF)

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Cancer communications (London, England), 2022-12, Vol.42 (12), p.1331-1346

2022

Volltextzugriff (PDF)

Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.76-82

2020

Volltextzugriff (PDF)

1 – 25 von 525

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Colloid And Interface Science

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(449)
Mit Volltextzugriff
(480)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(367)
Life Sciences & Biomedicine
(238)
Humans
(94)
Physical Sciences
(94)
Technology
(90)
Oncology
(66)
Animals
(65)
Chemistry
(58)
Female
(49)
Male
(48)
Engineering
(44)
Materials Science
(37)
Lung Cancer
(34)
Physics
(32)
Proteins
(29)
Mice
(28)
Middle Aged
(28)
Materials Science, Multidisciplinary
(26)
Tumors
(26)
Aged
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Pyrotinib in HER2 -Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers

A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer

Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7

Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study

Numerical simulation and validation of local wind environment of twin-box girder with wind barriers

Identification and validation of a pyroptosis-related signature in identifying active tuberculosis via a deep learning algorithm

Lung cancer in China: current and prospect

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC

Beyond Osimertinib: The Development of Third-Generation EGFR Tyrosine Kinase Inhibitors For Advanced EGFR+ NSCLC

Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway

TLR9 is a Cancer Stem Cell Maintenance Marker in Non-small Cell Lung Cancer

Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer

Advances in modeling boundary layer turbulence and its effects on motion independent aerodynamic force of bridge decks

A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease

Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody

Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction

Synchronous ground‐glass nodules showed limited response to anti‐PD‐1/PD‐L1 therapy in patients with advanced lung adenocarcinoma

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease

Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation

Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study

Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trials

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

Aktive Filter

Suchergebnisse filtern